Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for the treatment of severe lung inflammation, a condition with limited treatment options and a common cause of death following SARS‑CoV‑2 infection.
Contact us at team@exogenus-t.com
Company Details
- Employees
- 15
- Founded
- 2015
- Address
- Parque Tecnológico De Cantanhede, Cantanhede,portugal
- Phone
- +351 231 419 040
- te****@****s-t.com
- Industry
- Biotechnology
- Website
- exogenustherapeutics.com
- HQ
- Cantanhede
Exogenus Therapeutics Questions
Exogenus Therapeutics's helpline number is +351 231 419 040
Exogenus Therapeutics's website is exogenustherapeutics.com
Exogenus Therapeutics's LinkedIn profile is https://pt.linkedin.com/company/exogenus-therapeutics
Exogenus Therapeutics has
15 employees.
View email and phone details for 15
employees at Exogenus Therapeutics.
Exogenus Therapeutics's industry is
Biotechnology
Exogenus Therapeutics's top competitors are
Cellmabs,
Silicolife,
Bsim Therapeutics,
Biotrend Sa,
Luzitin Sa,
Immunethep,
Technophage, Sa,
Crioestaminal,
Valvian,
Ilof.
Exogenus Therapeutics's support email address is team@exogenus-t.com
Exogenus Therapeutics's categories are Biotechnology
Exogenus Therapeutics's founding year is 2015
